sb 239063 has been researched along with Vascular Diseases in 1 studies
SB 239063: structure in first source
SB-239063 : A member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively.
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ollinger, R | 1 |
| Thomas, M | 1 |
| Kogler, P | 1 |
| Hermann, M | 1 |
| Weiss, H | 1 |
| Mark, W | 1 |
| Bilban, M | 1 |
| Troppmair, J | 1 |
| Bach, FH | 1 |
| Margreiter, R | 1 |
1 other study available for sb 239063 and Vascular Diseases
| Article | Year |
|---|---|
Blockade of p38 MAPK inhibits chronic allograft vasculopathy.
Topics: Animals; Aorta; CD4 Antigens; CD8 Antigens; Graft Survival; Imidazoles; Mice; Mice, Inbred BALB C; M | 2008 |